We also showed that RIPK2 was involved in cell proliferation, apoptosis, and migration, while knockdown of RIPK2 had a suppressive effect on tumorigenesis in GC cells, by downregulating the NF-κB activation. The gene discussed is NFKB1; the disease is gastric cancer.